LAST: Local Anaesthetic Systemic Toxicity and Lipid Rescue

Few critical incidents are as recognisable in the viva — or as feared in real theatre — as local anaesthetic systemic toxicity (LAST). It is the moment a routine block tips into seizures and cardiovascular collapse, and the moment a calm, structured response saves a life. Solid command of local anaesthetic systemic toxicity treatment is high-yield for the EDAIC because it sits at the crossroads of pharmacology, regional anaesthesia and resuscitation — and because examiners love a scenario that tests whether you can recognise the problem early, stop the drug, support the airway and circulation, and reach for lipid emulsion at the right moment.

This article walks through the mechanism, the early and late clinical picture, the immediate management sequence and the lipid emulsion rescue protocol — framed as revision pointers. In genuine clinical practice, always follow your current AAGBI (now the Association of Anaesthetists) or ASRA guideline and your local protocol; the numbers below are the standard, guideline-consistent figures you should be able to recall under pressure.

What LAST actually is

Local anaesthetics work by blocking voltage-gated sodium channels, interrupting propagation of the action potential. That is exactly what we want in a peripheral nerve — but when plasma concentrations rise too high, the same channel blockade happens everywhere, most dangerously in the brain and the myocardium.

LAST is therefore a dose-and-concentration problem. It happens when local anaesthetic reaches the systemic circulation faster than the body can redistribute and metabolise it. The classic routes are:

• Accidental intravascular injection — the single commonest cause, and the reason aspiration, incremental dosing and ultrasound guidance matter.
• Absolute overdose — exceeding the maximum recommended dose, especially in small or frail patients.
• Rapid absorption from vascular tissue beds — intercostal and paravertebral blocks classically produce the highest peak plasma levels for a given dose.

Why some drugs are more dangerous than others

Not all local anaesthetics are equal. Bupivacaine is the textbook villain because it binds cardiac sodium channels avidly and dissociates slowly ("fast-in, slow-out"), making the cardiac arrest it causes notoriously refractory. Ropivacaine and levobupivacaine are the single-enantiomer agents developed partly to reduce this cardiotoxicity, and they are less cardiotoxic than racemic bupivacaine — though they are emphatically not risk-free. Lidocaine has a wider safety margin but is far from harmless in overdose.

Risk also rises with patient factors that examiners reward you for naming: extremes of age, low body weight, pregnancy, hepatic or renal impairment, low cardiac output states, and acidosis or hypoxia (both of which worsen cardiac toxicity and shift drug into the active, ionised form).

Recognising LAST: early and late features

The presentation exists on a spectrum, and the central exam point is that central nervous system signs usually precede cardiovascular collapse — but not always. Heavy sedation, general anaesthesia or a large rapid bolus can mask the warning phase, so the first sign you see may be a cardiac arrhythmia or arrest.

Early (prodromal) features

These reflect early CNS excitation as inhibitory pathways are blocked first:

• Perioral tingling and numbness of the tongue
• A metallic taste
• Tinnitus and visual disturbance
• Light-headedness, agitation, confusion
• Muscular twitching

Progressive and late features

As toxicity deepens:

• Generalised tonic-clonic seizures
• CNS depression, drowsiness and coma
• Cardiovascular collapse: bradycardia, conduction block, broad-complex arrhythmias, ventricular tachycardia or fibrillation, and asystole
• Profound hypotension and cardiac arrest

A useful revision anchor: any unexplained seizure, arrhythmia or arrest occurring during or shortly after a regional technique or large infiltration should be treated as LAST until proven otherwise. This is exactly the kind of pattern-recognition tested in the clinical sections — see our Paper B intensive care and clinical anaesthesia revision guide for how these critical-incident themes are framed.

Local anaesthetic systemic toxicity treatment: the core sequence

Effective local anaesthetic systemic toxicity treatment follows a logical, memorable sequence. Examiners want to hear you stop the insult, call for help, support the patient with standard resuscitation, and deploy lipid emulsion — in that order.

Step 1 — Stop and call for help

Immediately stop injecting the local anaesthetic. Call for help and declare the emergency clearly. Ask for the lipid emulsion and the cardiac arrest trolley to be brought to the room at once, because the lipid is the time-critical, LAST-specific intervention.

Step 2 — Airway, breathing, oxygenation

Secure the airway and give 100% oxygen. Effective ventilation is not a footnote here: hypoxia, hypercarbia and acidosis all dramatically worsen local anaesthetic cardiotoxicity and make resuscitation harder. Establishing oxygenation early can also raise the seizure threshold and stabilise the situation.

Step 3 — Control seizures

Suppress convulsions with a benzodiazepine as first line (for example midazolam). Small doses of thiopental or propofol may be used, but be cautious — propofol is not a substitute for lipid emulsion, and large doses can worsen hypotension in an already failing circulation. The goal is seizure control while protecting the airway and haemodynamics.

Step 4 — Manage the circulation and start CPR if needed

If the patient arrests, start standard CPR immediately and follow ALS principles, with important LAST-specific modifications:

• Lipid emulsion is given alongside CPR (see protocol below).
• If adrenaline is used, several guidelines favour smaller boluses (for example ≤1 microgram/kg) than the standard arrest dose, because large doses may impair the success of lipid resuscitation.
• Avoid vasopressin, calcium channel blockers, beta-blockers and lidocaine/local-anaesthetic-class antiarrhythmics.
• Treat ventricular arrhythmias with amiodarone rather than a local anaesthetic agent.
• Prolonged resuscitation may be necessary — recovery from bupivacaine-induced arrest can take well over an hour, so do not stop early. Consider cardiopulmonary bypass or extracorporeal support if available and the arrest is refractory.

The lipid emulsion rescue protocol

Lipid rescue is the intervention that makes LAST distinctive, and the last intralipid dose numbers are exactly the sort of recall examiners can convert into a true/false statement. Learn them as a clean, repeatable set.

How lipid emulsion is thought to work

The leading explanation is the "lipid sink" (or lipid shuttle) theory: the intravenous lipid emulsion creates an expanded lipid phase in the plasma that sequesters lipophilic local anaesthetic — bupivacaine especially — drawing it away from the myocardium and brain. Additional proposed mechanisms include a direct cardiotonic/metabolic effect, providing free fatty acids as a myocardial energy substrate and improving cardiac contractility. You do not need to commit to a single mechanism in the viva, but you should be able to name the lipid sink as the dominant hypothesis.

The standard dosing regimen (20% lipid emulsion)

The following is the widely taught, guideline-consistent lipid emulsion rescue protocol for an adult, based on 20% lipid emulsion. Always confirm against your current local guideline, because details and maxima are periodically revised.

For a quick worked mental model: a 70 kg adult receives roughly 100 mL as the initial bolus, followed by an infusion of around 1000 mL/hour. Continue the infusion until the patient is stable, and remember that boluses are repeated and the infusion rate escalated only if cardiovascular instability persists.

Practical points examiners reward

• Use lean (ideal) body weight for the calculation.
• Lipid emulsion is adjunctive — it does not replace high-quality CPR, oxygenation and seizure control.
• Continue standard resuscitation throughout lipid administration.
• After recovery, the patient needs monitoring in a critical care environment for at least several hours, because toxicity can recur as drug redistributes. Pancreatitis and disturbed laboratory assays are recognised after large lipid doses.
• Note the event and report it to your national registry/pharmacovigilance system where one exists.

Prevention: the question behind the question

Examiners frequently pivot from "treat this" to "how would you have prevented it?" Strong answers include:

• Use the lowest effective dose and calculate the maximum permissible dose for that patient in advance.
• Inject incrementally with intermittent aspiration; avoid a single large rapid bolus.
• Use ultrasound guidance to reduce intravascular injection.
• Consider a test dose and watch for early symptoms in an awake or lightly sedated patient.
• Know which blocks produce high peak levels (intercostal, paravertebral) and dose accordingly.
• Ensure lipid emulsion is immediately available wherever significant doses of local anaesthetic are used.

Pharmacology of the local anaesthetics — protein binding, pKa, lipid solubility and the determinants of toxicity — runs straight through this topic. If your drug knowledge feels shaky, the high-yield pharmacology topics breakdown maps the must-know agents, and the broader EDAIC Part 1 syllabus breakdown shows where regional anaesthesia and resuscitation sit across Paper A and Paper B.

How local anaesthetic toxicity is examined in the EDAIC

Because the Part 1 written exam uses the MTF (Multiple True/False) format — a stem followed by five statements (A–E), each judged independently as true or false — local anaesthetic toxicity in the EDAIC lends itself perfectly to discrete, testable facts. A single stem can probe the prodromal symptoms, the relative cardiotoxicity of bupivacaine versus ropivacaine, the lipid bolus dose, and the drugs to avoid, all in one question.

Remember the marking rules to your advantage: there is no negative marking (it was removed in 2014), so a wrong or blank statement simply scores zero — you should answer every statement, even where you are reasoning from first principles. The structured approach to these questions is covered in detail in our MTF technique and no-negative-marking strategy guide.

LAST is also prime SOE territory. In the structured oral examination (taken after passing Part 1, and generally conducted in English), a guided critical-incident scenario might begin with "you are called to recovery where a patient is convulsing after an axillary block" and unfold into a full management sequence. Rehearsing the spoken algorithm out loud is invaluable — see how the viva is structured in our EDAIC Part 2 oral exam (SOE) guide.

The most efficient way to lock these facts into long-term memory is repeated, spaced retrieval rather than passive re-reading. Drilling LAST as a set of discrete recall items — doses, sequence, drugs to avoid — in the AnesCORE EDAIC question bank builds exactly the rapid, reliable recall the exam rewards. Pair that with a spaced-repetition memory method so the numbers are still there months later on exam day.

A quick comparison: agents and relative cardiotoxicity

The headline you should be able to state cleanly: bupivacaine is the most cardiotoxic of the commonly used agents, and its single-enantiomer relatives were developed to mitigate that risk.

Putting it together for exam day

If you can deliver the following sequence fluently, you have the core of any LAST question, written or oral:

1. Recognise — seizure, arrhythmia or collapse during/after a regional technique.
2. Stop the local anaesthetic and call for help plus lipid emulsion.
3. Oxygenate and ventilate with 100% oxygen; secure the airway.
4. Control seizures with a benzodiazepine.
5. Support the circulation / start CPR with LAST-specific modifications (small adrenaline boluses, amiodarone, avoid lidocaine/vasopressin/calcium and beta-blockers).
6. Give 20% lipid emulsion — bolus ~1.5 mL/kg, infusion ~15 mL/kg/h, repeat and escalate as needed.
7. Continue prolonged resuscitation and transfer to critical care for monitoring and recurrence.

For broader pacing of your revision across all of these critical-incident topics, the effective EDAIC study plan shows how to fold high-yield clinical sets into a realistic schedule before the 2026 Part 1 written exam on 19 September 2026.

Frequently asked questions

What is the first step in local anaesthetic systemic toxicity treatment?

Stop injecting the local anaesthetic immediately, call for help, and ask for lipid emulsion and the arrest trolley. In parallel, secure the airway and give 100% oxygen, because correcting hypoxia and acidosis is essential before and during any further treatment. Lipid emulsion is the LAST-specific intervention, but it sits within standard resuscitation, not instead of it.

What is the lipid emulsion (intralipid) dose for LAST?

The widely taught, guideline-consistent regimen uses 20% lipid emulsion: an initial bolus of about 1.5 mL/kg of lean body weight over roughly a minute, followed by an infusion of about 15 mL/kg/hour. The bolus can be repeated up to twice more for persistent cardiovascular collapse, and the infusion can be doubled, with a commonly cited ceiling around 12 mL/kg total. Always confirm the exact figures against your current local or AAGBI/ASRA guideline.

Which local anaesthetic is most likely to cause cardiac arrest?

Racemic bupivacaine is the most cardiotoxic of the commonly used agents, owing to its avid, slowly reversible binding to cardiac sodium channels — the "fast-in, slow-out" pattern that makes the resulting arrest hard to reverse. Levobupivacaine and ropivacaine were developed as less cardiotoxic single-enantiomer alternatives, but neither is free of risk.

How is LAST tested in the EDAIC?

It commonly appears as MTF statements in the Part 1 written exam — testing prodromal symptoms, agent cardiotoxicity, lipid dosing and drugs to avoid — and as a structured critical-incident scenario in the Part 2 SOE. Because there is no negative marking, you should commit to a true or false judgement on every statement rather than leaving any blank.

Where can I confirm the official 2026 exam dates and registration details?

The confirmed Part 1 written date for this cycle is 19 September 2026. The 2026 registration window has already closed, so check the official ESAIC/EDAIC (myESAIC) website for the current deadline, fees and the next cycle's dates rather than relying on any figure quoted in a blog.

LAST rewards calm, drilled recall — exactly the kind of fluency that spaced practice builds. Create a free AnesCORE account to start structured revision, and put your LAST knowledge to the test in the EDAIC question bank where you can drill the doses, the sequence and the drugs to avoid until they are second nature.